Rotational Analyst

Role: The position is for a Rotational Analyst in a two-year program focused on biopharmaceutical strategy, investment, and R&D within Roivant Sciences. Objectives include evaluating licensing opportunities, conducting literature reviews for indication expansion, developing clinical trial acceleration strategies, and supporting strategic finance initiatives. Responsibilities encompass cross-functional project ownership across the company's pipeline and Vants, with exposure to early-stage biotech investments, clinical trial planning, and business development. Qualifications include enrollment in a U.S. undergraduate program in life sciences, business, or related fields, with a GPA of 3.5+, and graduation expected between December 2026 and June 2027. Candidates should demonstrate academic excellence, analytical curiosity, self-direction, and strong organizational skills. Preferred traits include ambition, creativity, resilience, and a passion for healthcare innovation. High-Value: The role supports a pipeline with multiple modalities and therapeutic areas, engaging in early to late-stage clinical projects and in-licensing activities. It involves strategic, operational, and financial analysis in a fast-paced, innovative environment. Location: On-site in New York, NY, with relocation required; no visa sponsorship. Compensation: Base salary of $100,000, with potential bonuses, equity, and benefits. The program emphasizes developing future leaders across biopharma, with opportunities to impact healthcare through diverse rotations and projects.